Results 101 to 110 of about 45,546 (194)

Prognostic impact of need for re-induction based on day-14 residual disease and age-adapted consolidation strategy in acute myeloid leukemia. [PDF]

Blood Cancer J
Bolarinwa A, Yousuf M, Al-Kali A, Alkhateeb HB, Mangaonkar AA, Saliba AN, Hefazi Torghabeh M, Matin A, Elliott MA, Litzow MR, Hogan WJ, Shah MV, Patnaik MM, Pardanani A, Chen D, Reichard KK, He R, Gangat N, Tefferi A, Begna KH.   +19 more
europepmc   +1 more source

A predictive model for cytarabine syndrome-associated febrile episodes in children with acute lymphoblastic leukemia. [PDF]

Front Pediatr
Wu Z, Zhu L, Liu Y, Lai F, Chen Z, Wen F, Mai H, Li X.   +7 more
europepmc   +1 more source

LEDGF/p75 Mediates Chemoresistance in Leukemia in a Context Dependent Manner. [PDF]

Cells
Akele TZ, Iglesias-Herrero C, Van Belle S, Pretto S, Christ F, Debyser Z.   +5 more
europepmc   +1 more source

Sample-Specific Generalized Cross-Validation for Gene Network Analysis of Cytarabine Response in Cancer Cell Lines. [PDF]

Int J Mol Sci
Oh J, Park H.
europepmc   +1 more source

Efficacy and safety of risk-stratified chemotherapy with azacitidine for children with myeloid leukaemia with Down syndrome: protocol for a multicentre phase II trial (JCCG AML-D24). [PDF]

BMJ Open
Nakashima K, Hasegawa D, Matsubayashi J, Tanaka S, Hama A, Yamato G, Kato S, Honda M, Nagai K, Goto H, Tsujimoto SI, Deguchi T, Niwa K, Hiramatsu H, Terui K, Toki T, Yoshida K, Kawai T, Saito AM, Moritake H, Taga T, Okamoto Y, Koh K, Tomizawa D.   +23 more
europepmc   +1 more source

Cross-Talk Between Histamine H₂ Receptor and Glucocorticoid Receptor: Potential Implications in Acute Myeloid Leukemia Treatment. [PDF]

Pharmacol Res Perspect
Torralba-Agu V, Fernández N, Shayo C, Davio C, Zappia CD, Monczor F.   +5 more
europepmc   +1 more source

Adult-Onset Central Nervous System Erdheim-Chester Disease Successfully Treated With Cladribine and Cytarabine: Case Report and Literature Review. [PDF]

EJHaem
Watanabe N, Yasuda H, Ishii M, Izumi N, Goto A, Inano T, Tomizawa Y, Hatano T, Ando M.   +8 more
europepmc   +1 more source

Exploiting Metabolic Vulnerabilities in Acute Myeloid Leukemia: Rationale and Evidence for Combining Metabolic Modulators with Conventional Chemotherapy. [PDF]

Pharmaceuticals (Basel)
Shams UA, Inayat F, Zeb MA, Maryam, Shams S, Ullah MJ, Jiménez-Morales S.   +6 more
europepmc   +1 more source

A complex mutational signature generated by cytarabine resistance. [PDF]

NAR Cancer
Cao D, Yin M, Bertoli R, Zhang Z, Lu A, Zhu J, Baslan T, Chung YJ, Negi V, Meltzer P, Aplan PD.   +10 more
europepmc   +1 more source

Long-Term Sequelae in Patients Treated for Recurrent CNS Relapses of Pediatric B-Cell Acute Lymphoblastic Leukemia: 20-Year Follow-Up, Neurological Consequences, and Survivorship Burden-A Case Report and Literature Review. [PDF]

Pediatr Rep
Niedźwiecki M, Lejman M, Czapliński M, Springer J, Synakiewicz A, Wasilewska E.   +5 more
europepmc   +1 more source